Cravath’s New York Office Moves to Two Manhattan West
March 19, 2024
Cravath represented Albemarle Corporation in connection with its $2.3 billion public offering of depositary shares, each representing a 1/20th interest in a share of Series A Mandatory Convertible Preferred Stock of Albemarle, at a public offering price of $50 per share. Albemarle leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. The transaction closed on March 8, 2024.
The Cravath team included partners Joseph D. Zavaglia, Michael E. Mariani and C. Daniel Haaren, of counsel Janice T. P. Martindale and associates Nadia T. Odai‑Afotey, Katie DelGhingaro and Joseph N. Kadoch on capital markets matters, partner Andrew T. Davis and associates Josh Banafsheha and William Swisher on tax matters, and practice area attorney David Crampton and associate Celine Li on executive compensation and benefits matters.
Deals & Cases
May 27, 2022
Cravath represented the underwriters in connection with the $1.7 billion senior notes offering of Albemarle Corporation, a leading global developer, manufacturer and marketer of highly engineered specialty chemicals. The transaction closed on May 13, 2022.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.